PGNY 📈 Progyny - Overview
Exchange: NASDAQ • Country: United States • Currency: USD • Type: Common Stock • ISIN: US74340E1038
PGNY: Fertility, Pharmacy, Adoption, Surrogacy, Doula, Travel
Progyny, Inc., a benefits management company, specializes in fertility and family building benefits solutions in the United States. Its fertility benefits solution includes differentiated benefits plan design, personalized concierge-style member support services, and selective network of fertility specialists. The company also offers Progyny Rx, an integrated pharmacy benefits solution that provides its members with access to the medications needed during their treatment. In addition, it provides assistance service programs where various services can be offered through a reimbursement program, including adoption, surrogacy, doula, and travel reimbursement when travel is required to receive medical services. The company was formerly known as Auxogyn, Inc. and changed its name to Progyny, Inc. in 2015. Progyny, Inc. was incorporated in 2008 and is headquartered in New York, New York. Web URL: https://www.progyny.com
Additional Sources for PGNY Stock
News:
Wall Street Journal
Benzinga
Yahoo Finance
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle
PGNY Stock Overview
| Market Cap in USD | 1,268m |
| Sector | Healthcare |
| Industry | Health Information Services |
| GiC Sub-Industry | Health Care Services |
| IPO / Inception | 2019-10-25 |
PGNY Stock Ratings
| Growth 5y | -50.8% |
| Fundamental | 47.2% |
| Dividend | - |
| Rel. Strength Industry | -2743 |
| Analysts | 3.6/5 |
| Fair Price Momentum | 11.08 USD |
| Fair Price DCF | 41.00 USD |
PGNY Dividends
No Dividends PaidPGNY Growth Ratios
| Growth Correlation 3m | -70.4% |
| Growth Correlation 12m | -95.9% |
| Growth Correlation 5y | -15.9% |
| CAGR 5y | -10.99% |
| CAGR/Mean DD 5y | -0.30 |
| Sharpe Ratio 12m | -1.43 |
| Alpha | -96.01 |
| Beta | 1.34 |
| Volatility | 50.36% |
| Current Volume | 6060.9k |
| Average Volume 20d | 1667.1k |
What is the price of PGNY stocks?
As of December 22, 2024, the stock is trading at USD 14.34 with a total of 6,060,892 shares traded.
Over the past week, the price has changed by -4.51%, over one month by +3.80%, over three months by -13.79% and over the past year by -61.63%.
As of December 22, 2024, the stock is trading at USD 14.34 with a total of 6,060,892 shares traded.
Over the past week, the price has changed by -4.51%, over one month by +3.80%, over three months by -13.79% and over the past year by -61.63%.
Is Progyny a good stock to buy?
Partly, yes. Based on ValueRay Fundamental Analyses, Progyny (NASDAQ:PGNY) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.18 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PGNY as of December 2024 is 11.08. This means that PGNY is currently overvalued and has a potential downside of -22.73%.
Partly, yes. Based on ValueRay Fundamental Analyses, Progyny (NASDAQ:PGNY) is currently (December 2024) ok to buy, but has to be watched. It has a ValueRay Fundamental Rating of 47.18 and therefor a somewhat positive outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of PGNY as of December 2024 is 11.08. This means that PGNY is currently overvalued and has a potential downside of -22.73%.
Is PGNY a buy, sell or hold?
Progyny has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold PGNY.
Progyny has received a consensus analysts rating of 3.60. Therefor, it is recommend to hold PGNY.
- Strong Buy: 3
- Buy: 0
- Hold: 7
- Sell: 0
- Strong Sell: 0
What are the forecast for PGNY stock price target?
According to ValueRays Forecast Model, PGNY Progyny will be worth about 12.4 in December 2025. The stock is currently trading at 14.34. This means that the stock has a potential downside of -13.25%.
According to ValueRays Forecast Model, PGNY Progyny will be worth about 12.4 in December 2025. The stock is currently trading at 14.34. This means that the stock has a potential downside of -13.25%.
| Issuer | Forecast | Upside |
|---|---|---|
| Wallstreet Target Price | 18.9 | 31.5% |
| Analysts Target Price | 49.1 | 242.7% |
| ValueRay Target Price | 12.4 | -13.2% |